Skip to content
Medical Health Aged Care, Seniors Interest

Research suggests higher intake of fruit reduces development of depression

Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney 2 mins read

Globally, depression is a major public health concern. According to the World Health Organisation it is the largest contributor to non-fatal burden of disease, with more than 80% of this burden represented across low- and middle-income countries.

A growing body of evidence suggests that dietary behaviours – in particular higher consumption of fruit and vegetables – may be important in reducing the risk of depression.

New research led by Post Doctoral Fellow Annabel Matison from UNSW Sydney’s Centre for Healthy Brain Ageing (CHeBA) has for the first time addressed the lack of research evidence that exists for older adults or for people in low- to middle-income countries.

“Compared with depression in younger adults, depression in older adults has a greater impact on physical performance and cognition and is associated with lower quality of life and higher death rate,” says Matison.

“Our aim with this study was to examine the associations between fruit and vegetable intake and depression in adults 45 years and older.”

Participants in the study came from multiple regions across six continents, including the United States, Sweden, Brazil, Nigeria, Malaysia and Australia. All data was collected and harmonised from ten longitudinal studies, with all groups part of the CHeBA-led Cohort Studies of Memory in an International Consortium (COSMIC).

The research, published in the Journal of Affective Disorders, assessed 7,801 community-based adults without depression, and revealed a beneficial association between higher fruit intake and lower risk of depression over the nine year period.

“This interesting finding of a protective association between fruit intake and risk of depression demonstrates a need to give a greater emphasis to diet in healthcare,” says Matison.

Although the results from this study suggested a benefit for the intake of vegetables, they were not statistically significant.

“The reason we found a beneficial relationship for fruit, but not vegetable intake, may be that vegetables are typically consumed cooked, which may impact their nutrient content, whereas fruit is generally consumed raw.”

Fruit and vegetable intake was self-reported via comprehensive food frequency questionnaire, short food questionnaire or diet history. Depressive symptoms were assessed using validated measures and depression defined applying validated cut-offs. The associations between baseline fruit and vegetable intakes and incident depression over a follow-up period of three to nine years were examined using the Cox regression method.

It has been suggested that the high levels of antioxidants, dietary fibre and vitamins contained in fruit and vegetables may exert a beneficial influence on depression through numerous mechanisms such as their role in inflammation, oxidative stress and the gut microbiota. As fruits and vegetables contain varying nutrients, it also seems likely that different types of fruit and vegetables may have differing impacts on the risk of depression. The evidence for citrus fruits and green leafy vegetables being associated with lower risk of depression is particularly strong.

CHeBA Co-Director and co-author on the research, Professor Henry Brodaty, said that future research considering the consumption of different types of fruit and vegetables using standardised measures and focusing on larger numbers of older adults is definitely warranted, particularly for low- and middle-income countries.

“The extension of current research being conducted into the genes associated with dietary intake provides a promising avenue to influence the intakes of fruit and vegetables,” says Professor Brodaty.

“We should also consider the types of fruit and vegetables consumed to better understand the relationships involved and studies should be designed to provide more comparability across cohorts,” he says.


  • ENDS –

Media contact:

Heidi Douglass, Centre for Healthy Brain Ageing, 0435 579 202

For more information about CHeBA:


Contact details:

Heidi Douglass


More from this category

  • Medical Health Aged Care
  • 24/06/2024
  • 17:07
Takeda Pharmaceutical Company Limited

Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies

LIVTENCITY Is the First and Only Post-Transplant Anti-CMV Treatment Approved in Japan That Targets/Inhibits UL97 Protein Kinase1 CMV Is One of the Most Common…

  • Contains:
  • CharitiesAidWelfare, Medical Health Aged Care
  • 24/06/2024
  • 16:20
National Rural Health Alliance

Community-led innovation to revolutionise healthcare access in rural Australia

The National Rural Health Alliance (the Alliance) is delighted that the Minister for Health and Aged Care, the Hon Mark Butler, has today announced…

  • Contains:
  • Business Company News, Medical Health Aged Care
  • 24/06/2024
  • 12:25
Jane Morgan Management

Imugene (ASX:IMU) Doses First Patient in Pioneering Phase 1 onCARlytics Trial

Sydney, Australia, 24 June 2024: Imugene Limited (ASX: IMU), a clinical-stage immuno-oncology company, is thrilled to announce the dosing of the first patient in the intravenous (IV) infusion combination arm of its Phase 1 onCARlytics (CF33-CD19) clinical trial. This groundbreaking trial, named OASIS, is being conducted at City of Hope in California and is designed to transform the treatment landscape for patients with advanced solid tumors. The OASIS trial is a world-first, combining a CD19-expressing oncolytic virus with a CD19-targeting drug. The trial aims to recruit 40-45 patients with advanced solid cancers that have metastasized, with preliminary early combination data…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.